Advertisement

Topics

QuintilesIMS now IQVIA as it aims to ‘outpace the inevitable progress of change’

12:21 EST 9 Nov 2017 | Outsourcing-Pharma

QuintilesIMS next week will officially be rebranded as IQVIA â the newest name in the âMega-CROâ category created by the rapid and ubiquitous consolidation of the industry.

Original Article: QuintilesIMS now IQVIA as it aims to ‘outpace the inevitable progress of change’

NEXT ARTICLE

More From BioPortfolio on "QuintilesIMS now IQVIA as it aims to ‘outpace the inevitable progress of change’"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...